Lafayette-based home health company LHC Group Inc. is reviewing strategies to increase its stock price and has hired J.P. Morgan Securities LLC as financial adviser.

Since May, LHC’s stock has fallen from more than $30 per share to as low as $12.34 in December. The stock has recovered somewhat and closed Tuesday at $17.13.

LHC said the company has not set a timetable to complete the process and there is no guarantee the review will result in “a transaction or strategic alternative of any kind.”

LHC also said the company does not plan to disclose developments or provide updates on its strategic review unless further disclosure is appropriate or required.